ADIL Med Monitor (@MedicationMon) profile picture

ADIL Med Monitor

@MedicationMon

APhA DrugInfoLine, published by the American Pharmacists Association, provides timely, relevant, interpreted drug news and information.

 Washington, DC
aphadruginfoline.com
Joined May 2011
  • Tweets1.5K
  • Following20
  • Followers291
FDA approves voxelotor (Oxbryta) for sickle cell disease apha.us/2LghYN5
Adalimumab-afzb, biosimilar to Humira, approved for multiple inflammatory conditions apha.us/2pRaysn
Acalabrutinib now approved for treatment of adults with CLL, SLL apha.us/2QWAJsR
Riluzole oral film approved for patients with ALS apha.us/2qNPRhc
Givosiran approved for acute hepatic porphyria apha.us/2OhuGgC
Cefiderocol approved to treat complicated urinary tract infections apha.us/2KUjjZP
FDA approves cenobamate tablets for adults with partial-onset seizures apha.us/2OnqaNL
Crizanlizumab-tmca (Adakveo), first targeted therapy, approved for patients with painful complication of sickle cell disease bit.ly/2KyI79y
New agent, #zanubrutinib (#Brukinsa), targets mantle cell lymphoma in adults who've received at least one prior therapy bit.ly/2NYK7KA
FDA approves luspatercept–aamt (Reblozyl), first therapy for beta thalassemia, a rare blood disorder bit.ly/36IoyW1
Sandoz receives approval for pegfilgrastim biosimilar bit.ly/32n16Kr
FDA approves Talicia, three-drug combination to treat H. pylori infection bit.ly/33rXMyY
FDA approves teriparatide injection (Bonsity) for osteoporosis bit.ly/2C1JbOy
First asenapine transdermal patch approved for treatment of adults with schizophrenia bit.ly/321ux4v
FDA approves Xofluza for people at high risk of developing flu-related complications bit.ly/2PBjYmi
First topical formulation of minocycline approved to treat acne bit.ly/2Nscn6O
Ravulizumab-cwvz approved for atypical hemolytic uremic syndrome bit.ly/326sfB8
Ustekinumab has new indication for treatment of adults with ulcerative colitis bit.ly/2WtE9nm
Niraparib approved for late-line treatment of women with recurrent ovarian cancer bit.ly/2pkNWjO
FDA approves delafloxacin for treatment of community-acquired bacterial pneumonia bit.ly/2qcW4m8
Load more